These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29437028)

  • 41. Endocannabinoid signaling and food addiction.
    D'Addario C; Micioni Di Bonaventura MV; Pucci M; Romano A; Gaetani S; Ciccocioppo R; Cifani C; Maccarrone M
    Neurosci Biobehav Rev; 2014 Nov; 47():203-24. PubMed ID: 25173635
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome.
    Bowles NP; Karatsoreos IN; Li X; Vemuri VK; Wood JA; Li Z; Tamashiro KL; Schwartz GJ; Makriyannis AM; Kunos G; Hillard CJ; McEwen BS; Hill MN
    Proc Natl Acad Sci U S A; 2015 Jan; 112(1):285-90. PubMed ID: 25535367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cannabinoid receptor 1 and its role in influencing peripheral metabolism.
    O'Keefe L; Simcocks AC; Hryciw DH; Mathai ML; McAinch AJ
    Diabetes Obes Metab; 2014 Apr; 16(4):294-304. PubMed ID: 23782485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders.
    Silvestri C; Di Marzo V
    Expert Opin Investig Drugs; 2012 Sep; 21(9):1309-22. PubMed ID: 22780328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa.
    Monteleone P; Matias I; Martiadis V; De Petrocellis L; Maj M; Di Marzo V
    Neuropsychopharmacology; 2005 Jun; 30(6):1216-21. PubMed ID: 15841111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Central and peripheral signaling mechanisms involved in endocannabinoid regulation of feeding: a perspective on the munchies.
    Sharkey KA; Pittman QJ
    Sci STKE; 2005 Mar; 2005(277):pe15. PubMed ID: 15798103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of CB1 receptor signaling: endocannabinoid modulation of synaptic strength.
    Mackie K
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S19-23. PubMed ID: 16570100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A role for the endocannabinoid system in obesity].
    Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
    Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review.
    Tortorella A; Brambilla F; Fabrazzo M; Volpe U; Monteleone AM; Mastromo D; Monteleone P
    Eur Eat Disord Rev; 2014 Sep; 22(5):307-20. PubMed ID: 24942507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?
    Bermudez-Silva FJ; Viveros MP; McPartland JM; Rodriguez de Fonseca F
    Pharmacol Biochem Behav; 2010 Jun; 95(4):375-82. PubMed ID: 20347862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endocannabinoid system: An overview of its potential in current medical practice.
    Mouslech Z; Valla V
    Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Altered brain reward circuits in eating disorders: chicken or egg?
    Frank GK
    Curr Psychiatry Rep; 2013 Oct; 15(10):396. PubMed ID: 23963630
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid involvement in feeding behaviour and the pathogenesis of certain eating disorders.
    Johnson RD
    Med Hypotheses; 1995 Nov; 45(5):491-7. PubMed ID: 8748094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of the Endocannabinoid System in Binge Eating Disorder.
    Bourdy R; Befort K
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Energy balance regulation by endocannabinoids at central and peripheral levels.
    Quarta C; Mazza R; Obici S; Pasquali R; Pagotto U
    Trends Mol Med; 2011 Sep; 17(9):518-26. PubMed ID: 21816675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.
    Heyman E; Gamelin FX; Aucouturier J; Di Marzo V
    Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocannabinoids, metabolic regulation, and the role of diet.
    Carr TP; Jesch ED; Brown AW
    Nutr Res; 2008 Oct; 28(10):641-50. PubMed ID: 19083471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endocannabinoid system and its role in energy regulation.
    Matias I; Di Marzo V
    Expert Rev Endocrinol Metab; 2006 Jul; 1(4):557-569. PubMed ID: 30290459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocannabinoid signaling and energy metabolism: a target for dietary intervention.
    Kim J; Li Y; Watkins BA
    Nutrition; 2011 Jun; 27(6):624-32. PubMed ID: 21470818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.